Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System
Recruiting now
Conditions studied: Venous Embolism of Lower Extremities (Diagnosis), Arterial Embolism and Thrombosis, Acute DVT of Lower Extremity, Chronic DVT of Lower Extremity, DVT, Deep Vein Thrombosis Leg, Thrombus in the Peripheral Venous Vasculature, Peripheral Arterial Disease, Acute Limb Ischemia, Lower Extremity Acute Limb Ischemia, LE ALI
In brief
The purpose of Case-Specific Health Care Professional (HCP) Clinical Survey of Liberant™ Thrombectomy System, also known as the Liberant Clinical Assessment, is to collect first-in-human clinical data to confirm the safety and performance of the Medtronic Liberant™ thrombectomy system when used for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems
Key facts
- Study ID
- NCT07335341
- Run by
- Medtronic Endovascular
- People needed
- 50
- Starts
- 2026-02-24
- Expected to finish
- 2026-10-01
- Last updated by the study team
- 2026-07-06
Who can join
Age: 22 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- MedStar Health — Washington D.C., District of Columbia, United States (enrolling)
- Naples Comprehensive Health — Naples, Florida, United States (enrolling)
- Mount Sinai — New York, New York, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.